Etid klinik pou Migrèn nan Tennessee
7 etid pou Migrèn ap chèche patisipan nan sit nan Tennessee.
Vil nan Tennessee
Tèks ofisyèl etid la (Anglè)
MMA Embolization for Refractory Chronic Migraine
- Semmes Murphey Foundation, Memphis
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT06735833A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Access Clinical Trials Inc /ID# 270280, Nashville
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 22, 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- University of Tennessee Health Science Center/ LeBonheur Children's Hospital, Memphis
Ap rekrite
Laj 10 a 17 · Tout sèks · Mizajou Sep 21, 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Vanderbilt Medical Center, Nashville
Ap rekriteFaz 4
Laj 18 a 70 · Tout sèks · Mizajou Sep 16, 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Access Clinical Trials, Inc. /ID# 228002, Nashville
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 14, 2026 · NCT05125302Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Clinical Research Associates, Inc., Nashville
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 2, 2026 · NCT07646613A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- WR-ClinSearch, LLC, Chattanooga
- Access Clinical Trials, Inc, Nashville
- Clinical Research Associates, Inc., Nashville
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 20, 2026 · NCT07645924Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.